To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MFSD5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
248 supporting clones for gene MFSD5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB451256 testis .a 1 to 478 1 to 479   tiling clone,   479/479
(100 %)
14 diff
(97.1 %id)
BX488015   .a 36 to 535 10 to 509   tiling clone,   500/509
(98 %)
6 diff
(98.9 %id)
NM_001170790.1   .a 367 to 2404 1 to 2038 exact RefSeq, AAA   2038/2038
(100 %)
0 diff
(100 %id)
DA565785 heart .a 368 to 869 2 to 503   capped   502/502
(100 %)
1 diff
(99.9 %id)
DA009879 adrenal gland .a 435 to 1008 2 to 575   capped   574/575
(99 %)
1 diff
(99.9 %id)
DA016140 adrenal gland .a 435 to 988 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA422739 cervix .a 436 to 993 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA080757 cerebellum .a 462 to 1033 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
BG697074 skin .a 488 to 1343 1 to 856   tiling clone,   856/856
(100 %)
1 diff
(99.9 %id)
CN366747 embryonic stem cells, cell lines H1, H7, andH9 .a 514 to 1192 1 to 678       678/678
(100 %)
3 diff
(99.6 %id)
AW239209 lung, cell line .b 1 to 427 1 to 427   tiling clone,   427/427
(100 %)
0 diff
(100 %id)
BX325318   .b 33 to 793 1 to 758   fully sequenced,   758/758
(100 %)
3 diff
(99.7 %id)
BC007703 Ovary, adenocarcinoma .b 43 to 1622 1 to 1580   tiling clone, available from MGC, AAA   1580/1580
(100 %)
0 diff
(100 %id)
TI_1948129469   .b 53 to 830 132 to 918       787/1097
(71 %)
24 diff
(97.9 %id)
TI_1948129470   .b 53 to 993 130 to 1089       960/1233
(77 %)
37 diff
(97.0 %id)
TI_1948129817   .b 53 to 723 129 to 803       675/1132
(59 %)
23 diff
(98.0 %id)
TI_1948129818   .b 53 to 911 127 to 985       859/1206
(71 %)
19 diff
(98.5 %id)
TI_1948130163   .b 53 to 790 129 to 866       738/1063
(69 %)
14 diff
(98.7 %id)
TI_1948130164   .b 53 to 907 123 to 982       860/1225
(70 %)
6 diff
(99.6 %id)
TI_1948130506   .b 53 to 611 129 to 688       560/1119
(50 %)
6 diff
(99.5 %id)
TI_1948130507   .b 53 to 837 127 to 925       799/1331
(60 %)
6 diff
(99.6 %id)
TI_1948232078   .b 53 to 1077 137 to 1172   AAA   1036/1239
(83 %)
38 diff
(97.0 %id)
TI_1948232079   .b 53 to 727 129 to 805   AAA   677/1151
(58 %)
27 diff
(97.7 %id)
TI_1948232381   .b 53 to 1066 136 to 1148       1013/1236
(81 %)
48 diff
(96.2 %id)
TI_1948232382   .b 53 to 815 130 to 902       773/1118
(69 %)
19 diff
(98.4 %id)
TI_1948232681   .b 53 to 1034 135 to 1120       986/1245
(79 %)
30 diff
(97.6 %id)
TI_1948232682   .b 53 to 795 135 to 880       746/1138
(65 %)
12 diff
(99.0 %id)
TI_1948232972   .b 53 to 1020 139 to 1101       963/1215
(79 %)
36 diff
(97.1 %id)
TI_1948232973   .b 53 to 795 132 to 880       749/1142
(65 %)
15 diff
(98.7 %id)
CV026788 mixed .b 54 to 646 1 to 591       591/598
(98 %)
3 diff
(99.5 %id)
EL736862 mixed .b 54 to 674 1 to 621       621/621
(100 %)
3 diff
(99.6 %id)
BG770625 melanotic melanoma, high MDR (cell line), skin .b 127 to 740 277 to 905       712/942
(75 %)
41 diff
(95.7 %id)
M79083   .b 163 to 561 1 to 401       401/404
(99 %)
5 diff
(98.8 %id)
TI_57178114   .b 190 to 1054 30 to 896       867/896
(96 %)
6 diff
(99.4 %id)
BI770187 pooled lung and spleen .b 192 to 1054 1 to 865       865/865
(100 %)
15 diff
(98.3 %id)
CN366748 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 193 to 653 1 to 461       461/461
(100 %)
5 diff
(99.0 %id)
AA307007 colon .b 222 to 633 1 to 414       414/414
(100 %)
2 diff
(99.6 %id)
AW954648   .b 223 to 499 1 to 277       277/277
(100 %)
25 diff
(91.0 %id)
CN366746 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 289 to 812 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
TI_1948129819   .b 293 to 1413 1230 to 118       1113/1236
(90 %)
0 diff
(100 %id)
TI_1948130165   .b 308 to 1413 1222 to 120       1103/1240
(88 %)
0 diff
(100 %id)
BF526017 brain, glioblastoma with EGFR amplification .b 313 to 1098 1 to 773       773/956
(80 %)
20 diff
(98.0 %id)
R02611 liver and spleen .b 314 to 665 7 to 372       366/419
(87 %)
20 diff
(95.3 %id)
TI_1948130508   .b 323 to 1413 1212 to 118       1095/1240
(88 %)
0 diff
(100 %id)
CF127419 Chondrosarcoma Lung Metastasis cell lines, lung .b 327 to 1124 1 to 798       798/798
(100 %)
1 diff
(99.9 %id)
TI_154192917   .b 327 to 1364 51 to 1082       1032/1037
(99 %)
24 diff
(97.7 %id)
TI_1948232683   .b 382 to 1413 1149 to 120       1030/1150
(89 %)
0 diff
(100 %id)
BE740339 adenocarcinoma cell line, ovary .b 390 to 803 365 to 783       554/791
(70 %)
31 diff
(96.1 %id)
TI_57152949   .b 408 to 1211 38 to 855       818/899
(90 %)
22 diff
(97.6 %id)
BI765060 pooled colon, kidney, stomach .b 409 to 1211 1 to 817       817/861
(94 %)
22 diff
(97.5 %id)
BP871606 embryonal kidney .b 419 to 951 1 to 533       533/543
(98 %)
2 diff
(99.7 %id)
TI_1948129471   .b 423 to 1413 1115 to 119       997/1204
(82 %)
0 diff
(100 %id)
TI_1948232081   .b 423 to 1413 1124 to 123       1002/1140
(87 %)
0 diff
(100 %id)
H98017.
matches multiple genes
melanocyte .b 426 to 867 1 to 445     also hits gene OPTN 445/450
(98 %)
14 diff
(96.9 %id)
TI_1948232975   .b 446 to 1413 1097 to 119       979/1154
(84 %)
0 diff
(100 %id)
CD634491   .b 450 to 1050 7 to 607       601/607
(99 %)
0 diff
(100 %id)
TI_59393579   .b 450 to 1247 59 to 854       796/796
(100 %)
4 diff
(99.5 %id)
BM015349 breast, mammary adenocarcinoma, cell line .b 451 to 1247 1 to 795       795/795
(100 %)
4 diff
(99.5 %id)
BU509556 leiomyosarcoma, uterus .b 454 to 1277 1 to 833       833/845
(98 %)
15 diff
(98.3 %id)
BF574940 muscle (skeletal) .b 456 to 781 1 to 326       326/326
(100 %)
0 diff
(100 %id)
BF725651 eye, Iris .b 473 to 994 1 to 522       522/522
(100 %)
0 diff
(100 %id)
TI_1948232384   .b 476 to 1413 1065 to 119       947/1179
(80 %)
0 diff
(100 %id)
TI_1948130166   .b 489 to 1413 1040 to 116       925/1041
(88 %)
0 diff
(100 %id)
AL529419 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 495 to 1551 1 to 1043   AAA   1043/1081
(96 %)
16 diff
(98.6 %id)
TI_1948129820   .b 498 to 1413 1018 to 117       902/1027
(87 %)
0 diff
(100 %id)
BE769784 prostate_tumor .b 508 to 917 1 to 407       407/415
(98 %)
9 diff
(97.9 %id)
TI_1948130509   .b 517 to 1413 1020 to 116       905/1053
(85 %)
0 diff
(100 %id)
N25418 melanocyte .b 520 to 838 1 to 320       320/430
(74 %)
13 diff
(97.0 %id)
TI_1948129472   .b 530 to 1413 1002 to 120       883/1002
(88 %)
0 diff
(100 %id)
W28516 eye, retina .b 536 to 897 87 to 446       360/490
(73 %)
5 diff
(99.0 %id)
BX353120 Neuroblastoma Cot 25-normalized .b 556 to 829 1 to 262   fully sequenced,   262/262
(100 %)
8 diff
(97.0 %id)
CD634492   .b 590 to 1232 649 to 8       642/649
(98 %)
6 diff
(99.1 %id)
AA457681   .b 612 to 1031 1 to 419     Submitted on the opposite strand 419/419
(100 %)
4 diff
(99.1 %id)
BI222439 cervical carcinoma cell line, cervix .b 614 to 1424 1 to 807       807/808
(99 %)
12 diff
(98.6 %id)
BX402892   .b 615 to 1569 964 to 17       948/998
(94 %)
0 diff
(100 %id)
BQ217610 melanotic melanoma, skin .b 630 to 1394 1 to 785   AAA   785/809
(97 %)
27 diff
(96.7 %id)
AL580492 T cells from T cell leukemia .b 651 to 1590 940 to 1       940/940
(100 %)
29 diff
(97.0 %id)
BM015271 breast, mammary adenocarcinoma, cell line .b 660 to 1163 243 to 756       612/757
(80 %)
35 diff
(95.4 %id)
TI_59393498   .b 660 to 1163 292 to 805       613/758
(80 %)
35 diff
(95.4 %id)
TI_1948232080   .b 676 to 1413 883 to 141       743/1212
(61 %)
0 diff
(100 %id)
BX426466 T cells (Jurkat cell line) .b 688 to 1621 1 to 929       929/929
(100 %)
8 diff
(99.2 %id)
EL946366 eyeball .b 759 to 1388 1 to 630       630/630
(100 %)
5 diff
(99.3 %id)
BX325317   .b 763 to 1611 844 to 1   fully sequenced,   844/844
(100 %)
8 diff
(99.1 %id)
BX350824 Neuroblastoma Cot 25-normalized .b 799 to 1618 818 to 1   fully sequenced,   818/818
(100 %)
14 diff
(98.3 %id)
EC504121 Prostate .b 803 to 893 95 to 5       91/95
(95 %)
0 diff
(100 %id)
R63404 placenta .b 837 to 1264 1 to 438   fully sequenced,   438/438
(100 %)
19 diff
(95.7 %id)
BM820296 stomach .b 848 to 1050 1 to 203       203/203
(100 %)
0 diff
(100 %id)
BM821546 stomach .b 848 to 1255 1 to 413       413/413
(100 %)
13 diff
(96.9 %id)
FN157291 breast carcinoma .b 873 to 939 1 to 67       67/70
(95 %)
2 diff
(97.2 %id)
BQ332166 lung_tumor .b 881 to 1316 18 to 449       432/449
(96 %)
6 diff
(98.7 %id)
W26097 eye, retina .b 886 to 1440 577 to 18       560/602
(93 %)
0 diff
(100 %id)
BE538942 cervix .b 889 to 1602 1 to 716       716/724
(98 %)
37 diff
(94.9 %id)
TI_1948232974   .b 910 to 1413 645 to 139       507/1180
(42 %)
0 diff
(100 %id)
BQ014518 Chondrosarcoma, Left Pubic Bone .b 912 to 1620 728 to 19   AAA   710/710
(100 %)
1 diff
(99.9 %id)
AA306638 aorta .b 940 to 1235 1 to 296       296/296
(100 %)
0 diff
(100 %id)
CU452615 epidermis .b 949 to 1196 24 to 271       248/281
(88 %)
1 diff
(99.7 %id)
H19703 brain .b 951 to 1355 1 to 408       408/418
(97 %)
10 diff
(97.7 %id)
W60725 heart .b 960 to 1115 8 to 163   fully sequenced,   156/163
(95 %)
4 diff
(97.6 %id)
BU622768 cell lines, Enchondroma .b 995 to 1622 646 to 19   AAA   628/628
(100 %)
0 diff
(100 %id)
AW995351 breast_normal .b 1026 to 1531 506 to 1     Submitted on the opposite strand 506/506
(100 %)
3 diff
(99.5 %id)
AI346051 adenocarcinoma, colon .b 1059 to 1624 574 to 9       566/574
(98 %)
0 diff
(100 %id)
AW968959   .b 1072 to 1619 35 to 581       547/610
(89 %)
7 diff
(98.9 %id)
AA489157 germinal center B cell .b 1084 to 1570 1 to 486       486/486
(100 %)
3 diff
(99.4 %id)
W60685 heart .b 1085 to 1623 547 to 1   fully sequenced,   547/547
(100 %)
15 diff
(97.3 %id)
BU754237 placenta .b 1097 to 1620 544 to 21       524/544
(96 %)
0 diff
(100 %id)
AV700634 hepatocellular carcinoma .b 1102 to 1622 523 to 3       521/523
(99 %)
0 diff
(100 %id)
BQ447212 Knee, Osteoarthritic Cartilage .b 1116 to 1620 523 to 19   AAA   505/514
(98 %)
0 diff
(100 %id)
BU537786 mixed (pool of 40 RNAs) .b 1136 to 1622 1 to 487       487/767
(63 %)
2 diff
(99.8 %id)
CN366749 embryonic stem cells, DMSO-treated H9 cellline .b 1139 to 1565 1 to 427       427/427
(100 %)
0 diff
(100 %id)
AW001238 colon, colonic mucosa from 3 patients with Crohn'sdisease .b 1144 to 1622 482 to 4       479/482
(99 %)
0 diff
(100 %id)
BF589047 sciatic nerve .b 1144 to 1622 481 to 3       479/481
(99 %)
0 diff
(100 %id)
AW470553 carcinoid, lung .b 1148 to 1622 476 to 2       475/476
(99 %)
0 diff
(100 %id)
AL134105 brain .b 1154 to 1548 33 to 427       395/427
(92 %)
6 diff
(98.6 %id)
AI246795 adenocarcinoma, colon .b 1167 to 1624 466 to 9       458/466
(98 %)
0 diff
(100 %id)
AI453704 adenocarcinoma, Pancreas .b 1173 to 1622 450 to 1       450/450
(100 %)
0 diff
(100 %id)
N20513 melanocyte .b 1174 to 1623 452 to 1       452/453
(99 %)
3 diff
(99.4 %id)
H23708 brain .b 1177 to 1618 470 to 7       464/470
(98 %)
0 diff
(100 %id)
AI347013 adenocarcinoma, colon .b 1179 to 1624 449 to 4       446/449
(99 %)
0 diff
(100 %id)
BF447332 Prostate .b 1180 to 1623 444 to 1       444/444
(100 %)
1 diff
(99.8 %id)
DB516738 testis .b 1191 to 1622 1 to 432   AAA Submitted on the opposite strand 432/432
(100 %)
8 diff
(98.2 %id)
AI283173 adenocarcinoma, colon .b 1191 to 1624 437 to 4       434/437
(99 %)
0 diff
(100 %id)
AA464914   .b 1197 to 1622 426 to 1     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
AA576465 breast, breast tumor .b 1218 to 1623 406 to 1       406/406
(100 %)
0 diff
(100 %id)
W02727 heart .b 1237 to 1622 387 to 1       387/387
(100 %)
1 diff
(99.8 %id)
BF111568 pooled .b 1240 to 1623 384 to 1       384/384
(100 %)
0 diff
(100 %id)
BF437217 Prostate .b 1240 to 1621 387 to 6       382/387
(98 %)
0 diff
(100 %id)
R63358 placenta .b 1246 to 1623 387 to 1   fully sequenced,   387/387
(100 %)
12 diff
(96.9 %id)
H97395 melanocyte .b 1266 to 1623 363 to 1       363/363
(100 %)
5 diff
(98.7 %id)
CB957738 Pooled-Glandular .b 1272 to 1622 1 to 351       351/395
(88 %)
2 diff
(99.5 %id)
AI865518 normal prostate, Prostate .b 1287 to 1623 337 to 1       337/337
(100 %)
5 diff
(98.6 %id)
EC579407 Prostate .b 1299 to 1390 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
EC522653 Prostate .b 1309 to 1388 19 to 96       78/96
(81 %)
6 diff
(93.8 %id)
CD107511 brain, Pituitary .b 1315 to 1622 26 to 333   AAA   308/333
(92 %)
6 diff
(98.2 %id)
R01671 liver and spleen .b 1325 to 1605 291 to 1       291/350
(83 %)
11 diff
(96.9 %id)
AA069551   .b 1334 to 1623 290 to 1       290/290
(100 %)
0 diff
(100 %id)
AA887419 Kidney .b 1341 to 1622 284 to 2       283/284
(99 %)
0 diff
(100 %id)
AI264441 adenocarcinoma, colon .b 1344 to 1624 285 to 4       282/285
(98 %)
0 diff
(100 %id)
BF839376 head_neck .b 1356 to 1510 1 to 153       153/153
(100 %)
2 diff
(98.7 %id)
AA555155 normal prostatic epithelial cells, Prostate .b 1366 to 1624 266 to 8       259/266
(97 %)
0 diff
(100 %id)
AJ289878   .b 1367 to 1622 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AA514544 colon .b 1387 to 1621 236 to 2       235/236
(99 %)
0 diff
(100 %id)
AI583572 adenocarcinoma, Pancreas .b 1422 to 1622 201 to 1       201/201
(100 %)
0 diff
(100 %id)
AI005179 breast .b 1433 to 1622 190 to 1       190/190
(100 %)
0 diff
(100 %id)
AW196200 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 1501 to 1624 128 to 5       124/128
(96 %)
0 diff
(100 %id)
AL554939 placenta, Placenta Cot 25-normalized .c 1 to 884 8 to 883   fully sequenced,   883/883
(100 %)
4 diff
(99.6 %id)
AL558736 T cells from T cell leukemia .c 1 to 872 8 to 874       874/878
(99 %)
8 diff
(99.1 %id)
BX402893   .c 1 to 920 8 to 924       924/929
(99 %)
4 diff
(99.6 %id)
BM763616 myeloma .c 1 to 376 8 to 383       383/383
(100 %)
0 diff
(100 %id)
BM764061 myeloma .c 1 to 208 8 to 216       216/216
(100 %)
1 diff
(99.6 %id)
BM764084 myeloma .c 1 to 500 8 to 507       507/507
(100 %)
0 diff
(100 %id)
BM781993 myeloma .c 1 to 605 8 to 612       612/612
(100 %)
0 diff
(100 %id)
DA488272 brain .c 1 to 467 8 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
DA581527 lung .c 1 to 457 8 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
BF689924 melanotic melanoma, high MDR (cell line), skin .c 1 to 781 6 to 826       727/1226
(59 %)
44 diff
(96.5 %id)
DB032674 testis .c 1 to 539 7 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
AL047123 uterus .c 1 to 394 5 to 399       399/399
(100 %)
3 diff
(99.3 %id)
BI914370 brain .c 1 to 851 4 to 855       855/857
(99 %)
5 diff
(99.5 %id)
TI_57242976   .c 1 to 851 35 to 886       855/888
(96 %)
11 diff
(98.8 %id)
DR760982 embryonic stem .c 1 to 771 2 to 772   tiling clone,   772/772
(100 %)
1 diff
(99.9 %id)
BM844094 myeloma .c 1 to 582 2 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BM849427 myeloma .c 1 to 537 2 to 539       539/539
(100 %)
5 diff
(99.1 %id)
BQ932937 large cell carcinoma, lung .c 1 to 742 1 to 757       757/1001
(75 %)
21 diff
(98.0 %id)
DA983375 synovial membrane tissue from rheumatioidarthritis .c 1 to 564 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
AL544036 placenta, Placenta Cot 25-normalized .c 3 to 802 1 to 794   fully sequenced,   794/794
(100 %)
4 diff
(99.5 %id)
BM553278 brain, medulla .c 3 to 429 1 to 429       429/1032
(41 %)
6 diff
(99.5 %id)
BI916905 brain .c 6 to 732 1 to 727       727/727
(100 %)
0 diff
(100 %id)
TI_57239562   .c 6 to 732 37 to 763       727/763
(95 %)
6 diff
(99.3 %id)
BU527003 epidermoid carcinoma, cell line, lung .c 10 to 692 1 to 683       683/683
(100 %)
1 diff
(99.9 %id)
BM913369 amelanotic melanoma, cell line, skin .c 12 to 717 1 to 708       708/1146
(61 %)
12 diff
(99.0 %id)
BE877799 large cell carcinoma, undifferentiated, lung .c 17 to 877 1 to 853       853/965
(88 %)
50 diff
(94.9 %id)
BI918619 brain .c 18 to 810 7 to 810       804/813
(98 %)
26 diff
(96.9 %id)
BI915575 brain .c 18 to 861 1 to 844       844/844
(100 %)
6 diff
(99.3 %id)
TI_57238545   .c 18 to 810 7 to 810       804/813
(98 %)
26 diff
(96.9 %id)
TI_57238844   .c 18 to 861 35 to 878       844/878
(96 %)
12 diff
(98.7 %id)
BI911886 leukocyte .c 33 to 807 28 to 801       774/803
(96 %)
11 diff
(98.7 %id)
TI_57232603   .c 33 to 807 28 to 801       774/803
(96 %)
11 diff
(98.7 %id)
BI915908 brain .c 43 to 785 1 to 743       743/745
(99 %)
4 diff
(99.5 %id)
TI_57244433   .c 43 to 785 33 to 775       743/777
(95 %)
10 diff
(98.8 %id)
TI_45212704   .c 45 to 907 82 to 945       864/946
(91 %)
35 diff
(96.4 %id)
BG773139 testis .c 48 to 631 1 to 592       592/593
(99 %)
11 diff
(98.2 %id)
TI_57239693   .c 49 to 883 27 to 863       837/863
(96 %)
11 diff
(98.8 %id)
DB056196 testis .c 49 to 603 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BI601017 brain, hypothalamus .c 51 to 907 1 to 858       858/859
(99 %)
30 diff
(96.6 %id)
BI092048 cervix .c 52 to 529 1 to 479       479/482
(99 %)
3 diff
(99.4 %id)
BI758816 pooled colon, kidney, stomach .c 52 to 943 1 to 899       899/899
(100 %)
35 diff
(96.2 %id)
BI772807 pooled lung and spleen .c 52 to 680 28 to 657       631/657
(96 %)
14 diff
(97.9 %id)
TI_57146109   .c 52 to 943 70 to 968       899/968
(92 %)
41 diff
(95.8 %id)
TI_57178955   .c 52 to 680 28 to 657       631/657
(96 %)
14 diff
(97.9 %id)
BF982862 duodenal adenocarcinoma, cell line, small intestine .c 53 to 795 1 to 742       742/796
(93 %)
29 diff
(96.4 %id)
BI916174 brain .c 53 to 883 1 to 833       833/833
(100 %)
5 diff
(99.4 %id)
TI_57244333   .c 53 to 851 24 to 822       799/822
(97 %)
12 diff
(98.6 %id)
AY358604   .c 55 to 1748 1 to 1694 exact tiling clone, AAA   1694/1694
(100 %)
1 diff
(100.0 %id)
BC067795 Brain, hypothalamus .c 56 to 1748 1 to 1693 L130M tiling clone, available from MGC, AAA   1693/1693
(100 %)
2 diff
(99.9 %id)
BG911308 anaplastic oligodendroglioma with 1p/19qloss, brain .c 57 to 851 1 to 806       806/970
(83 %)
22 diff
(97.8 %id)
DA605735   .c 58 to 595 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA690604   .c 58 to 512 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
BG528928 adenocarcinoma, Prostate .c 59 to 858 1 to 804       804/804
(100 %)
28 diff
(96.6 %id)
BI916034 brain .c 59 to 851 1 to 793       793/793
(100 %)
7 diff
(99.2 %id)
CN366750 embryonic stem cells, DMSO-treated H9 cellline .c 62 to 816 1 to 755       755/755
(100 %)
1 diff
(99.9 %id)
DN996083 breast cancer, Mammary gland (cancer tissue) .c 63 to 611 1 to 550       550/550
(100 %)
4 diff
(99.3 %id)
DA450003 tongue, tumor tissue .c 64 to 614 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BM809047 brain, hippocampus .c 66 to 960 10 to 906       897/987
(90 %)
17 diff
(98.3 %id)
TI_57147068   .c 66 to 851 25 to 814       790/815
(96 %)
15 diff
(98.2 %id)
AL556349 placenta .c 70 to 913 23 to 858   fully sequenced,   836/858
(97 %)
9 diff
(99.0 %id)
BI761334 pooled colon, kidney, stomach .c 71 to 851 1 to 785       785/786
(99 %)
12 diff
(98.5 %id)
BI761353 pooled colon, kidney, stomach .c 72 to 735 1 to 661       661/662
(99 %)
4 diff
(99.4 %id)
BI835606 pooled pancreas and spleen .c 72 to 840 1 to 767       767/767
(100 %)
2 diff
(99.8 %id)
TI_57147088   .c 72 to 735 63 to 723       661/724
(91 %)
7 diff
(99.1 %id)
TI_57167206   .c 72 to 840 33 to 799       767/799
(95 %)
7 diff
(99.2 %id)
BI837146 pooled pancreas and spleen .c 73 to 992 1 to 918       918/919
(99 %)
13 diff
(98.6 %id)
TI_57167825   .c 73 to 992 71 to 988       918/989
(92 %)
19 diff
(98.1 %id)
CN366745 embryonic stem cells, cell lines H1, H7, andH9 .c 75 to 822 13 to 760       748/760
(98 %)
7 diff
(99.1 %id)
BG769269 melanotic melanoma, high MDR (cell line), skin .c 75 to 619 1 to 545       545/742
(73 %)
1 diff
(99.9 %id)
BM839967 myeloma .c 75 to 614 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
BM848083 myeloma .c 75 to 609 1 to 534       534/534
(100 %)
4 diff
(99.3 %id)
BX376703 Neuroblastoma Cot 50-normalized .c 76 to 1091 1 to 1002       1002/1057
(94 %)
19 diff
(98.3 %id)
AL552646 placenta, Placenta Cot 25-normalized .c 76 to 919 1 to 835   fully sequenced,   835/835
(100 %)
6 diff
(99.3 %id)
AL560747 B cells from Burkitt lymphoma .c 76 to 887 1 to 791   fully sequenced,   791/791
(100 %)
8 diff
(99.0 %id)
BQ072939 leukocyte .c 78 to 1072 1 to 1014       1014/1046
(96 %)
43 diff
(95.9 %id)
BM906302 ovary (pool of 3) .c 81 to 719 14 to 656       643/1194
(53 %)
23 diff
(98.1 %id)
BM008154 Spleen .c 87 to 891 1 to 804       804/806
(99 %)
9 diff
(98.9 %id)
TI_59383634   .c 87 to 891 71 to 874       804/806
(99 %)
9 diff
(98.9 %id)
BX640649 human colon endothel primary cell culture .c 90 to 1740 1 to 1651 G425E available from DKFZ, AAA   1651/1651
(100 %)
1 diff
(100.0 %id)
BQ430638 epithelioid carcinoma, Pancreas .c 91 to 943 36 to 898       863/911
(94 %)
34 diff
(96.3 %id)
CX755505 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 92 to 809 1 to 718     Submitted on the opposite strand 718/718
(100 %)
1 diff
(99.9 %id)
BM543639 brain, hippocampus .c 94 to 740 21 to 669       649/1093
(59 %)
12 diff
(99.0 %id)
BM919398 pooled pancreas and spleen .c 95 to 750 1 to 660       660/1252
(52 %)
13 diff
(99.0 %id)
AK225998   .c 99 to 1748 1 to 1650 exact AAA   1650/1650
(100 %)
1 diff
(100.0 %id)
BE315042 adenocarcinoma cell line, ovary .c 99 to 739 1 to 636       636/709
(89 %)
13 diff
(98.2 %id)
AL528941 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 100 to 853 1 to 752   fully sequenced,   752/752
(100 %)
3 diff
(99.7 %id)
BX415001 thymus .c 103 to 862 1 to 752       752/892
(84 %)
64 diff
(92.9 %id)
BE873017 adenocarcinoma, colon .c 104 to 795 1 to 694       694/781
(88 %)
22 diff
(97.2 %id)
AL534846 brain, fetal brain .c 107 to 951 1 to 840   fully sequenced,   840/840
(100 %)
1 diff
(99.9 %id)
AL555944 placenta .c 107 to 936 1 to 821   fully sequenced,   821/821
(100 %)
0 diff
(100 %id)
BU157288 ductal carcinoma, cell line, Pancreas .c 111 to 977 1 to 866       866/1060
(81 %)
41 diff
(96.2 %id)
BQ877999 ductal carcinoma, cell line, Pancreas .c 111 to 635 1 to 531       531/1325
(40 %)
28 diff
(97.9 %id)
BI906822 leukocyte .c 124 to 844 1 to 719       719/719
(100 %)
2 diff
(99.8 %id)
TI_57233294   .c 124 to 844 64 to 782       719/782
(91 %)
7 diff
(99.2 %id)
CB107470 Liver .c 146 to 595 1 to 450       450/450
(100 %)
1 diff
(99.8 %id)
AK074684 mammary gland .c 161 to 1747 175 to 1761 V157A available from FLJ,   1761/1761
(100 %)
5 diff
(99.8 %id)
DA082042 cerebellum .c 161 to 457 177 to 473   capped   472/472
(100 %)
3 diff
(99.4 %id)
DA428788 colon .c 161 to 501 178 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DA646789 mammary gland .c 161 to 680 175 to 686   capped   685/693
(98 %)
13 diff
(98.2 %id)
DA667398 esophagus .c 161 to 555 175 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
NM_032889.4   .c 161 to 1748 178 to 1765 exact RefSeq, AAA   1765/1765
(100 %)
0 diff
(100 %id)
DA695979   .c 161 to 544 177 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
AL570277 placenta, Placenta Cot 25-normalized .c 772 to 1688 916 to 1   fully sequenced,   916/916
(100 %)
9 diff
(99.1 %id)
AL528940 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 823 to 1721 899 to 1   fully sequenced,   899/899
(100 %)
9 diff
(99.0 %id)
AL577536 placenta, Placenta Cot 25-normalized .c 854 to 1701 863 to 25   fully sequenced,   839/863
(97 %)
12 diff
(98.7 %id)
AL582149 B cells from Burkitt lymphoma .c 857 to 1715 857 to 1   fully sequenced,   857/857
(100 %)
15 diff
(98.3 %id)
BF690150 melanotic melanoma, high MDR (cell line), skin .c 869 to 1708 866 to 24       843/1245
(67 %)
0 diff
(100 %id)
AL578632 placenta .c 883 to 1699 841 to 35   fully sequenced,   807/841
(95 %)
7 diff
(99.2 %id)
AL552603 placenta, Placenta Cot 25-normalized .c 889 to 1728 841 to 8   fully sequenced,   834/841
(99 %)
5 diff
(99.5 %id)
AL578311 placenta .c 906 to 1708 813 to 21   fully sequenced,   793/813
(97 %)
20 diff
(97.6 %id)
AL565683 brain, fetal brain .c 921 to 1738 799 to 1   fully sequenced,   799/799
(100 %)
4 diff
(99.5 %id)
BX415000 thymus .c 1060 to 1718 669 to 8       662/825
(80 %)
0 diff
(100 %id)
DB361549 mammary gland .c 1202 to 1747 540 to 1       540/541
(99 %)
15 diff
(97.3 %id)
DA977615 synovial membrane tissue from rheumatioidarthritis .d 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
2 diff
(99.7 %id)
BG425921 Kidney .d 19 to 1518 1 to 685 V6A N11Q Q12P G13R D14R ... tiling clone,   610/885
(68 %)
34 diff
(96.2 %id)
AI525674 Prostate Gene MFSD5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AK097576 testis Gene MFSD5, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AA428297 ovarian tumor, ovary Gene MFSD5, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AA428729 ovarian tumor, ovary Gene MFSD5, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BU599912 mixed (pool of 40 RNAs) Gene MFSD5, variant not shown         Suspected internal deletion, this clone was ignored    
DB039003 testis Gene MFSD5, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB337680 testis Gene MFSD5, variant not shown         Suspected internal deletion, this clone was ignored    
BM689434 eye, Retina Foveal and Macular Gene MFSD5, variant not shown         Suspected internal deletion, this clone was ignored    
BU726599 eye, Retina Foveal and Macular Gene MFSD5, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C